Cargando…

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer

Mostrar otras versiones (1)

BACKGROUND: Understanding what constitutes an important difference on a HRQL measure is critical to its interpretation. The aim of this study was to provide a range of estimates of minimally important differences (MIDs) in EQ-5D scores in cancer and to determine if estimates are comparable in lung c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pickard, A Simon, Neary, Maureen P, Cella, David
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248572/ https://www.ncbi.nlm.nih.gov/pubmed/18154669 http://dx.doi.org/10.1186/1477-7525-5-70

Ejemplares similares

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
por: Pickard, A Simon, et al.
Publicado: (2010)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

Correspondence between EQ-5D health state classifications and EQ VAS scores
por: Whynes, David K
Publicado: (2008)

Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke
por: Kim, Sang-Kyu, et al.
Publicado: (2015)

Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness
por: Lin, D-Yin, et al.
Publicado: (2023)

Does the correspondence between EQ-5D health state description and VAS score vary by medical condition?
por: Whynes, David K
Publicado: (2013)

A longitudinal validation of the EQ-5D-5L and EQ-VAS stand-alone component utilising the Oxford Hip Score in the Australian hip arthroplasty population
por: Lin, D-Yin, et al.
Publicado: (2022)

Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease
por: Bae, Eunmi, et al.
Publicado: (2020)

Estimation of minimally important difference of the EQ-5D-5L utility scores among patients with either hypertension or diabetes or both: a cross-sectional study in Hong Kong
por: XU, Richard Huan, et al.
Publicado: (2020)

Assessing the performance of the EQ-VAS in the NHS PROMs programme
por: Feng, Yan, et al.
Publicado: (2013)

Minimal Clinically Important Differences in EQ-5D-5L Index and VAS after a Respiratory Muscle Training Program in Individuals Experiencing Long-Term Post-COVID-19 Symptoms
por: del Corral, Tamara, et al.
Publicado: (2023)

Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?
por: Barton, Garry R, et al.
Publicado: (2008)

The minimal important change for the EQ VAS based on the SF-36 health transition item: observations from 25772 spine surgery procedures
por: Joelson, Anders, et al.
Publicado: (2022)

Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score
por: Dakin, Helen, et al.
Publicado: (2012)

Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents
por: Åström, Mimmi, et al.
Publicado: (2022)

EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets
por: Jiang, Ruixuan, et al.
Publicado: (2022)

Validity of EQ-5D-5L in stroke
por: Golicki, Dominik, et al.
Publicado: (2014)

Preoperative predictors of health-related quality of life changes (EQ-5D and EQ VAS) after total hip and knee replacement: a systematic review
por: Schatz, Caroline, et al.
Publicado: (2022)

Population-Based Preference Weights for the EQ-5D Health States Using the Visual Analogue Scale (VAS) in Iran
por: Goudarzi, Reza, et al.
Publicado: (2016)

Valuation of EQ-5D-3l Health States in Slovenia: VAS Based and TTO Based Value Sets
por: Prevolnik Rupel, Valentina, et al.
Publicado: (2020)

Mapping the Oxford Shoulder Score onto the EQ-5D utility index
por: Valsamis, Epaminondas M., et al.
Publicado: (2022)

Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden
por: Teni, Fitsum Sebsibe, et al.
Publicado: (2023)

Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder
por: Desroziers, Katia, et al.
Publicado: (2013)

Valuation of the EQ-5D-5L in Taiwan
por: Lin, Hsiang-Wen, et al.
Publicado: (2018)

Calculation of Minimally Clinically Important Difference in VAS, SF-36, and LSA Scores for Hallux Rigidus Correction Via MTP Fusion
por: Manz, Wesley J., et al.
Publicado: (2022)

Determinants of the acceptability of health problems in different ages: exploring a new application of the EQ VAS
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study
por: Janssen, M. F., et al.
Publicado: (2012)

Responsiveness and minimal clinically important difference of the EQ-5D-5L in cervical intraepithelial neoplasia: a longitudinal study
por: Hu, Xin, et al.
Publicado: (2020)

Estimating EQ-5D utilities based on the Short-Form Long Term Conditions Questionnaire (LTCQ-8)
por: Tsiachristas, Apostolos, et al.
Publicado: (2020)

Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression
por: Ali, Faraz Mahmood, et al.
Publicado: (2017)

Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China
por: Sun, Sun, et al.
Publicado: (2014)

Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
por: Abdin, Edimansyah, et al.
Publicado: (2018)

Combining EQ-5D-5L items into a level summary score: demonstrating feasibility using non-parametric item response theory using an international dataset
por: Feng, You-Shan, et al.
Publicado: (2021)

Reporting and valuing one’s own health: a think aloud study using EQ-5D-5L, EQ VAS and a time trade-off question among patients with a chronic condition
por: Ernstsson, Olivia, et al.
Publicado: (2020)

US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples
por: Jiang, Ruixuan, et al.
Publicado: (2020)

General population normative data for the EQ-5D-3L in the five largest European economies
por: Janssen, Mathieu F., et al.
Publicado: (2021)

EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria
por: Hawe, Emma, et al.
Publicado: (2016)

Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis
por: Koszorú, Kamilla, et al.
Publicado: (2022)

Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea
por: Lim, Jaeok, et al.
Publicado: (2019)

Estimating the EQ-5D-5L value set for the Philippines
por: Miguel, Red Thaddeus D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5u3gfugusesthqjmr6rs0jm05n